A phase I single ascending dose trial of PL 37 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 25 Nov 2011
At a glance
- Drugs PL 37 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- 25 Nov 2011 Planned number of patients changed to 92.
- 25 Nov 2011 Status changed from not yet recruiting to completed.
- 13 Oct 2008 New trial record.